Filing metadata

Accession number
0000897069-24-000285
Form type
Form 3
Filer
Telomir Pharmaceuticals, Inc.
CIK
CIK 1971532
Filed
Feb 08, 2024
Reporting period
Feb 08, 2024
Description
Initial ownership

Explore SEC Filings Hub